At Advocate's second simulation center, clinicians and others practice improving patient safety.
Proteus makes digital sensors for pills that track medication adherence, including in Abilify Mycite, the first of such drugs to receive FDA approval.
With continuous advancements in technology, the healthcare landscape is rapidly changing. Providers are looking for ways to deliver faster, more personalized care to their patients while improving communications within their care teams. Technology can help providers achieve these goals and Apple...
Researchers at Imperial College London have shown that a toxin from the Peruvian green velvet tarantula was able to alleviate pain.
U.S. regulators approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.
Sanford Health added to its growing international portfolio by acquiring a minority stake in Isar Klinikum, a hospital based in Munich. Sanford plans to work intimately with the German hospital on stem cell therapy.
The blue agave plant is already being investigated as the source of treatments for osteoporosis and lowering blood glucose, and now is being used as the raw material in a bio-skin to treat second-and third-degree burns.
A Silicon Valley innovation company is coming to Cleveland Clinic to create an accelerator focused on biotech and digital health innovation.
A research team from Queen Mary University of London developed a very fast dissolving "bioactive" glass that can be used in toothpaste or dental fillings to repair decayed teeth.
A new study in Scientific Reports finds that microscopic particles from tattoo ink can migrate into the lymph nodes.
Federal regulators have approved the first continuous blood sugar monitor for diabetics that doesn't need backup finger prick tests.
A new study looks at whether testosterone directly affects decisions that drive up prices and destabilize markets.